Chen Mao
31Patents
5h-index
44Co-inventors
69Inventor score
Filing activity: Mar 17, 1997 → Jun 1, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5806638A | Pull rod base of luggage | Human Necessities | 10 | Expired |
| US5998411A | Heterocyclic nonnucleoside inhibitors of reverse transcriptase | Chemistry; Metallurgy | 9 | Expired |
| US6329420A | Tubulin binding compounds (COBRA) | Chemistry; Metallurgy | 9 | Expired |
| US6335364B1 | Synthetic spiroketal pyranes as potent anti-cancer agents | Chemistry; Metallurgy | 8 | Expired |
| US6258841A | Tubulin binding compounds (COBRA) | Chemistry; Metallurgy | 5 | Expired |
| US10246461B2 | Dosage form compositions comprising an inhibitor of bruton's tyrosine kinase | Chemistry; Metallurgy | 2 | Active |
| US6124307A | Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and methods for use thereof | Chemistry; Metallurgy | 2 | Expired |
| US6300351A | Beta-fluoroethyl thiourea compounds and use | Chemistry; Metallurgy | 1 | Expired |
| US9421182B2 | Cocrystals of dimethyl fumarate | Emerging Cross-Sectional Technologies | 1 | Active |
| US9416096B2 | Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use | Emerging Cross-Sectional Technologies | 1 | Active |
| US6156759A | Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and method for use thereof | Chemistry; Metallurgy | 1 | Expired |
| US6180654A | Heterocyclic nonnucleoside inhibitors of reverse transcriptase | Chemistry; Metallurgy | 1 | Expired |
| US6380190B1 | Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and methods for use thererof | Chemistry; Metallurgy | 1 | Expired |
| US8399513B2 | Levodopa prodrug mesylate hydrate | Chemistry; Metallurgy | 1 | Active |
| US9670252B2 | Fusion expression of G-protein coupled receptor | Chemistry; Metallurgy | 0 | Active |
| US6512003B2 | Synthetic spiroketal pyranes as potent anti-cancer agents and use | Chemistry; Metallurgy | 0 | Expired |
| US10221231B2 | Method of expressing a G-protein coupled receptor protein | Chemistry; Metallurgy | 0 | Active |
| US7919505B2 | Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound | Human Necessities | 0 | Active |
| US8435562B2 | Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use | Human Necessities | 0 | Active |
| US8722733B2 | Levodopa prodrug mesylate hydrate | Chemistry; Metallurgy | 0 | Active |
| US6794541B2 | Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction | Physics | 0 | Expired |
| US9895336B2 | Crystalline forms of (N, N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use | Emerging Cross-Sectional Technologies | 0 | Active |
| US10106595B2 | Nucleic acid sequence encoding a fusion protein | Chemistry; Metallurgy | 0 | Active |
| US10716760B2 | Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9795581B2 | Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.